Open AccessBrentuximab vedotin in the treatment of a patient with refractory H odgkin disease and P roteus syndrome – a case report and discussion
Author(s) -
Myakova Natalia,
Smirnova Nadezhda,
Evstratov Dmitry,
Abugova Yulia,
Balashov Dmitry,
Diakonova Yulia,
Konovalov Dmitry,
Skvortsova Yulia,
Maschan Alexey
Publication year - 2015
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.297
Subject(s) - brentuximab vedotin , medicine , refractory (planetary science) , lymphoma , oncology , disease , hodgkin lymphoma , physics , astrobiology
Key Clinical Message Treatment of patients with refractory Hodgkin lymphoma is a significant issue. We report a patient with Proteus syndrome and relapsed Hodgkin lymphoma, whose remission was finally achieved after brentuximab vedotin therapy, allowing her to receive a haploidentical stem cell transplant. The possible relationship between both disorders was discussed.